About Douglas Godshall
Douglas Godshall is an executive officer and director at Galvanize Therapeutics.
Douglas Godshall reports to the SEC as a director or officer of 4 public companies, including Shockwave Medical (SWAV), EyePoint (EYPT) and Immunic (IMUX).
Douglas Godshall first appears on SEC filings in 2007.
Experience
This experience comes from SEC filings. The years are when the filings name Douglas Godshall in the role, so the role may have started earlier or lasted longer.
SI
Shockwave Medical, Inc.
President & CEO, director
2019 – 2024 · Public company (SWAV)
EI
EyePoint, Inc.
Director
2012 – 2021 · Public company (EYPT)
II
Immunic, Inc.
Director
2014 – 2018 · Public company (IMUX)
HI
HeartWare International, Inc.
President & Chief Exec Officer, director
2007 – 2016 · Public company (HTWR)
Key Colleagues at Startups
The people Douglas Godshall works with at each company, as listed on that company's latest Form D.
Galvanize Therapeutics, Inc. · Form D, Sep 11, 2025
JW
Jonathan Waldstreicher
Executive officer
AP
Antoine Papiernik
Director
DL
David Lewis
Director
SA
SH
Seth Harrison
Director
ZS
Zack Scott
Director